カテゴリ： Allied Market Research, 世界, 医療/バイオ

高齢者及び身体障害者支援装置の世界市場：生活用品、移動補助機器、浴室用安全装置、医療用家具

◆英語タイトル：Elderly and Disabled Assistive Devices Market by Type (Living Aids, Mobility Assistive Devices, Bathroom Safety Equipment, and Medical Furniture): Global Opportunity Analysis and Industry Forecast, 2019–2026
◆商品コード：AMR9NV079
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2019年7月
◆ページ数：202
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,370 ⇒換算￥579,960見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算￥696,600見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算￥971,460見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
当調査レポートでは、高齢者及び身体障害者支援装置の世界市場について調査・分析し、市場概要、種類別（生活補助、移動補助機器、浴室の安全装置、医療用家具）分析、地域別分析、企業動向など含め、以下の構成でお届け致します。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・高齢者及び身体障害者支援装置の世界市場：種類別（生活補助、移動補助機器、浴室の安全装置、医療用家具）
・高齢者及び身体障害者支援装置の世界市場：地域別
・企業動向

【レポートの概要】

The global elderly & disabled assistive devices market size was $23,009 million in 2018 and is anticipated to reach $35,599 million by 2026, registering a CAGR of 5.5% from 2019 to 2026. Assistive devices, as the term signifies are the medical devices that assist elderly as well as disabled people to form their various basic tasks such as walking, hearing problems, vision problems, and others. The mobility aids devices include wheelchairs, scooters, and others that alleviate disabled individuals with their mobility. Moreover, there are various kinds of hearing aids that help individuals with hearing difficulties such as Behind-the-ear Aids (BTE), Receiver-in-the-Ear Aids (RITE), In-the‐Ear Aids (ITE), Bone Anchored Hearing Aids (BAHA), canal hearing aids and cochlear implants.

The global elderly and disabled assistive devices market is primarily driven by significant rise in mobility impairment disorders, lifestyle changes, and availability of a variety of disabled & elderly assistive products. In addition, considerable increase in demand for assistive devices due to rise in trend of an independent lifestyle further fuels the market growth. Furthermore, growth in the number of assistive devices manufacturers investing in the R&D activities of these technologies is estimated to boost the market growth. However, high cost of few sophisticated products, low level of acceptance for few products, and low reimbursement from medical insurers restrain the growth of the market. On the contrary, an increase in proactiveness of people and rise in health consciousness among people are anticipated to provide lucrative growth opportunities for the market growth.

The global elderly & disabled assistive devices market is segmented based on type and region. Based on type, it is divided into living aids, mobility aids devices, medical furniture, and bathroom safety equipment. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• This report provides an extensive analysis of the emerging trends and dynamics in the global elderly & disabled assistive devices market.
• This study provides the landscape of the global market to predict the competitive environment across geographies.
• This report entails the detailed quantitative analyses of the current trends and future estimations to identify the prevailing opportunities.
• Comprehensive analyses of factors that drive and restrict the market growth is provided in the report.
• Region- and country-wise analysis is conducted to understand the market trends and dynamics.

KEY MARKET SEGMENTS
By Type
• Living Aids Devices
o Hearing Aids
 Behind-the-ear Aids (BTE)
 Receiver-in-the-Ear Aids (RITE)
 In-the‐Ear Aids (ITE)
 Bone Anchored Hearing Aids (BAHA)
 Canal Hearing Aids
 Cochlear Implants
o Reading and Vision Aids
 Braille Translators
 Video Magnifiers
 Reading Machines
 Others
• Mobility Aids Devices
o Wheelchairs
 Manual Wheelchairs
 Powered Wheelchairs
o Mobility Scooters
 Walkers & Rollators
 Canes & Walking Sticks
 Crutches
 Transfer Lifts or Patient Mechanical Lift Handling
 Door Openers
 Others
• Medical Furniture
o Medical Beds
o Door Openers
o Medical Furniture Accessories
o Riser Reclining Chairs
o Others
• Bathroom Safety Equipment
o Shower Chairs
o Commodes
o Ostomy Products
o Bars, Grips, & Rails
• By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Australia
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA

The key players profiled in this report are as follows:
• AI Squared
• Drive Medical.
• GN Resound Group.
• Invacare
• William Demant Holding A/S
• Nordic Capital (Sunrise Medical LLC)
• Pride Mobility Products Corporation
• Siemens Ltd
• Sonova Holding AG
• Starkey hearing technologies
The other players operating in the elderly & disabled assistive devices market include (not profiled in the report)
• Bausch & Lomb, Inc.,
• Inclusive Technology Ltd.
• Liberator Ltd.
• Tobii Dynavox
• JABBLA B.V.B.A
• Blue Chip Medical Type, Inc.
• Permobil AB
• Medline Industries, Inc.

【レポートの目次】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s Five Forces Analysis
3.4. Regulatory Framework

3.4.1. FDA (U.S. Food and Drug Administration)
3.4.2. Health Canada
3.4.3. CE Mark

3.5. Market Share Analysis
3.6. Market Dynamics

3.6.1. Drivers

3.6.1.1. Growth in geriatric and disabled population
3.6.1.2. High disposable income of baby boomers
3.6.1.3. Technological advancements in assistive devices

3.6.2. Restraints

3.6.2.1. High cost of medical devices
3.6.2.2. Low reimbursement from medical insurers

3.6.3. Opportunities

3.6.3.1. Emerging untapped economies

CHAPTER 4: ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Living Aids

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast

4.2.2.1. Hearing Aids

4.2.2.1.1. Market size and forecast
4.2.2.1.2. BTE (Behind-the-ear) Aids

4.2.2.1.2.1. Market size and forecast

4.2.2.1.3. RITE (Receiver-in-the-Ear) Aids

4.2.2.1.3.1. Market size and forecast

4.2.2.1.4. ITE (In-the?Ear) Aids

4.2.2.1.4.1. Market size and forecast

4.2.2.1.5. BAHA (Bone Anchored Hearing Aids)

4.2.2.1.5.1. Market size and forecast

4.2.2.1.6. Canal Hearing Aids

4.2.2.1.6.1. Market size and forecast

4.2.2.1.7. Cochlear Implants

4.2.2.1.7.1. Market size and forecast

4.2.2.2. Reading and Vision Aids

4.2.2.2.1. Market size and forecast
4.2.2.2.2. Braille translators

4.2.2.2.2.1. Market size and forecast

4.2.2.2.3. Video Magnifiers

4.2.2.2.3.1. Market size and forecast

4.2.2.2.4. Reading Machines

4.2.2.2.4.1. Market size and forecast

4.2.2.2.5. Others

4.2.2.2.5.1. Market size and forecast

4.3. Mobility Aids Devices

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Wheelchairs

4.3.4.1. Market size and forecast
4.3.4.2. Manual Wheelchairs

4.3.4.2.1. Market size and forecast

4.3.4.3. Powered Wheelchairs

4.3.4.3.1. Market size and forecast

4.3.5. Mobility Scooters

4.3.5.1. Market size and forecast
4.3.5.2. Walkers and Rollators

4.3.5.2.1. Market size and forecast

4.3.5.3. Crutches and Canes

4.3.5.3.1. Market size and forecast

4.3.5.4. Patient Mechanical Lift Handling

4.3.5.4.1. Market size and forecast

4.3.5.5. Others

4.3.5.5.1. Market size and forecast

4.4. Medical furniture

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Medical Beds

4.4.4.1. Market size and forecast

4.4.5. Door Openers

4.4.5.1. Market size and forecast

4.4.6. Riser Reclining Chairs

4.4.6.1. Market size and forecast

4.4.7. Others

4.4.7.1. Market size and forecast

4.5. Bathroom Safety Equipment

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Shower Chairs

4.5.4.1. Market size and forecast

4.5.5. Commode Chairs

4.5.5.1. Market size and forecast

4.5.6. Ostomy Equipment

4.5.6.1. Market size and forecast

4.5.7. Bars, Grips, and Rails

4.5.7.1. Market size and forecast

CHAPTER 5: ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast, by product type

5.2.3.1. Market size and forecast, by living aids devices
5.2.3.2. Market size and forecast, by mobility aids devices
5.2.3.3. Market size and forecast, by medical furniture devices
5.2.3.4. Market size and forecast, by bathroom safety equipment
5.2.3.5. Market size and forecast, by country

5.2.3.5.1. U.S. market size and forecast
5.2.3.5.2. Canada market size and forecast
5.2.3.5.3. Mexico market size and forecast

5.3. Europe

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast, by product type

5.3.3.1. Market size and forecast, by living aids devices
5.3.3.2. Market size and forecast, by mobility aids devices
5.3.3.3. Market size and forecast, by medical furniture devices
5.3.3.4. Market size and forecast, by bathroom safety equipment
5.3.3.5. Market size and forecast, by country

5.3.3.5.1. Germany market size and forecast
5.3.3.5.2. France market size and forecast
5.3.3.5.3. UK market size and forecast
5.3.3.5.4. Italy market size and forecast
5.3.3.5.5. Spain market size and forecast
5.3.3.5.6. Rest of Europe market size and forecast

5.4. Asia-Pacific

5.4.1. Key market trends
5.4.2. Market size and forecast, by product

5.4.2.1. Market size and forecast, by living aids devices
5.4.2.2. Market size and forecast, by mobility aids devices
5.4.2.3. Market size and forecast, by medical furniture devices
5.4.2.4. Market size and forecast, by bathroom safety equipment
5.4.2.5. Market size and forecast by country

5.4.2.5.1. Japan market size and forecast
5.4.2.5.2. China market size and forecast
5.4.2.5.3. India market size and forecast
5.4.2.5.4. Australia market size and forecast
5.4.2.5.5. South Korea market size and forecast

5.4.2.6. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast, by products

5.5.3.1. Market size and forecast, by living aids devices
5.5.3.2. Market size and forecast, by mobility aids devices
5.5.3.3. Market size and forecast, by medical furniture devices
5.5.3.4. Market size and forecast, by bathroom safety equipment
5.5.3.5. Market size and forecast by country

5.5.3.5.1. Brazil market size and forecast
5.5.3.5.2. South Africa market size and forecast
5.5.3.5.3. Saudi Arabia market size and forecast
5.5.3.5.4. Rest of LAMEA market size and forecast

CHAPTER 6: COMPANY PROFILES

6.1. AI SQUARED

6.1.1. Company Overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Key strategic moves and developments

6.2. DRIVE MEDICAL

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Key strategic moves and developments

6.3. GN RESOUND GROUP

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Key strategic moves and deve9lopments
6.3.6. Business performance

6.4. INVACARE CORPORATION

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments

6.5. NORDIC CAPITAL (SUNRISE MEDICAL LLC)

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Key strategic moves and developments

6.6. PRIDE MOBILITY PRODUCTS CORPORATION

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Key strategic moves and developments

6.7. SIEMENS AG

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.7.6. Key strategic moves and developments

6.8. SONOVA HOLDING AG

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.8.6. Key strategic moves and developments

6.9. STARKEY HEARING TECHNOLOGIES

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Key strategic moves and developments

6.10. WILLIAM DEMANT HOLDING A/S

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance

LIST OF TABLES

TABLE 01. FEW TYPES UNDER DIFFERENT CLASSES OF HEALTH CANADA
TABLE 02. GLOBAL ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 03. GLOBAL LIVING AIDS DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 04. GLOBAL HEARING AIDS MARKET FOR LIVING AIDS DEVICES, BY TYPE, 2018–2026 ($MILLION)
TABLE 05. GLOBAL READING AND VISION AIDS DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 06. GLOBAL MOBILITY AIDS DEVICES MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 07. GLOBAL MEDICAL FURNITURE MARKET, BY TYPE 2018–2026 ($MILLION)
TABLE 08. GLOBAL BATHROOM SAFETY EQUIPMENT’S MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 09. ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 11. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY LIVING AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MOBILITY AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MEDICAL FURNITURE DEVICES, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY BATHROOM SAFETY EQUIPMENT, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 17. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY LIVING AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 18. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MOBILITY AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 19. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MEDICAL FURNITURE DEVICES, 2018–2026 ($MILLION)
TABLE 20. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY BATHROOM SAFETY EQUIPMENT, 2018–2026 ($MILLION)
TABLE 21. EUROPE ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 22. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 23. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY LIVING AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 24. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MOBILITY AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 25. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MEDICAL FURNITURE DEVICES, 2018–2026 ($MILLION)
TABLE 26. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY BATHROOM SAFETY EQUIPMENT, 2018–2026 ($MILLION)
TABLE 27. ASIA-PACIFIC ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 28. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 29. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY LIVING AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 30. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MOBILITY AIDS DEVICES, 2018–2026 ($MILLION)
TABLE 31. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY MEDICAL FURNITURE, 2018–2026 ($MILLION)
TABLE 32. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY BATHROOM SAFETY EQUIPMENT, 2018–2026 ($MILLION)
TABLE 33. LAMEA ELDERLY AND DISABLED ASSISTIVE DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 34. AI SQUARED: COMPANY SNAPSHOT
TABLE 35. AI SQUARED OPERATING SEGMENTS
TABLE 36. AI SQUARED PRODUCT PORTFOLIO
TABLE 37. DRIVE MEDICAL COMPANY SNAPSHOT
TABLE 38. DRIVE MEDICAL OPERATING SEGMENTS
TABLE 39. DRIVE MEDICAL: PRODUCT PORTFOLIO
TABLE 40. GN RESOUND GROUP: COMPANY SNAPSHOT
TABLE 41. GN RESOUND GROUP: OPERATING SEGMENTS
TABLE 42. GN RESOUND GROUP: PRODUCT/ SERVICE PORTFOLIO
TABLE 43. INVACARE: COMPANY SNAPSHOT
TABLE 44. INVACARE: OPERATING SEGMENTS
TABLE 45. INVACARE: PRODUCT PORTFOLIO
TABLE 46. NORDIC CAPITAL SNAPSHOT
TABLE 47. NORDIC CAPITAL: OPERATING SEGMENT
TABLE 48. PRIDE MOBILITY PRODUCTS: COMPANY SNAPSHOT
TABLE 49. PRIDE MOBILITY PRODUCTS OPERATING SEGMENT
TABLE 50. PRIDE MOBILITY PRODUCTS: PRODUCT/ SERVICE PORTFOLIO
TABLE 51. SIEMENS AG: COMPANY SNAPSHOT
TABLE 52. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 53. SIEMENS AG: PRODUCT PORTFOLIO
TABLE 54. SIEMENS AG KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 55. SONOVA: COMPANY SNAPSHOT
TABLE 56. SONOVA: OPERTAING SEGMENT
TABLE 57. SONOVA: PRODUCT PORTFOLIO
TABLE 58. SONOVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 59. STARKEY HEARING TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 60. STARKEY HEARING TECHNOLOGIES: OPERATING SEGMENTS
TABLE 61. STARKEY HEARING TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 62. STARKEY HEARING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63. WILLIAM DEMANT: COMPANY SNAPSHOT
TABLE 64. WILLIAM DEMANT: OPERATING SEGMENTS
TABLE 65. WILLIAM DEMANT PRODUCT PORTFOLIO

【レポートのキーワード】

高齢者及び身体障害者支援装置、生活補助、移動補助機器、浴室の安全装置、医療用家具

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[高齢者及び身体障害者支援装置の世界市場：生活用品、移動補助機器、浴室用安全装置、医療用家具]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 腫瘍治療薬の日本市場：化学療法、標的療法、免疫療法、ホルモン療法
    AMR9NV118 / Allied Market Research / 2019年8月 / ...The Japan oncology drugs market accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. Cancer is a serious medical condition marked by the presence of tumor cells present in the body. The formation of tumor cells take place when the normal cells grow at an abnormal rate. Moreover, these tumor cells also have the ability to spread to other parts of the body through blood and lymphatic system. In addition, cancer has different stages which are based on the growth pattern of tumor. Therefore, the...
  2. 腫瘍治療薬の中国市場：化学療法、標的療法、免疫療法、ホルモン療法
    AMR9NV120 / Allied Market Research / 2019年8月 / ...The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer according to the data published by WHO. Being the most populous country in the world, cancer rates are significantly rising in China. As per Global Cancer Observatory in 2018, the number of new cancer cases registered each year in China...
  3. 経口タンパク質・ペプチドの世界市場：医薬品種類別（リナクロチド、プレカナチド、カルシトニン、インシュリン、オクトレオチド）、用途別（消化器疾患、骨疾患、糖尿病、ホルモン障害）
    AMR8040011 / Allied Market Research / 2018年3月15日 / 本資料は、経口タンパク質・ペプチドの世界市場について調べ、経口タンパク質・ペプチドの世界規模、市場動向、市場環境、医薬品種類別（リナクロチド、プレカナチド、カルシトニン、インシュリン、オクトレオチド）分析、用途別（消化器疾患、骨疾患、糖尿病、ホルモン障害）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・経口タンパク質・ペプチドの世界市場概要 ・経口タンパク質・ペプチドの世界市場環境 ・経口タンパク質・ペプチドの世界市場動向 ・経口タンパク質・ペプチドの世界市場規模 ・経口タンパク質・ペプチドの世界市場：医薬品種類別（リナクロチド、プレカナチド、カルシトニン、インシュリン、オクトレオチド） ・経口タンパク質・ペプチドの世界市場：用途別（消化器疾患、骨疾患、糖尿病、ホルモン障害） ・経口タンパク質・ペプチドの世界市場：地域別市場規模・分析...The peptide and protein therapeutics are an important class of medicines, which are administered through the oral route to treat different diseases, which include gastric, hormonal, and metabolic disorders. These drugs hold significant potential to improve the human health. The global oral proteins and peptides market was valued at $643 million in 2016, and is estimated to reach at $8,233 million by 2028, registering a CAGR of 11.7% from 2022 to 2028. Upsurge in collaboration between pharmaceutical companies for drug development and surge in prevalence of chronic diseases are the key factors that augment the growth of the global oral...
  4. がん治療法の世界市場：用途別、人気商品別
    AMR9NV072 / Allied Market Research / 2019年7月 / 当調査レポートでは、がん治療法の世界市場について調査・分析し、市場概要、用途別（血液がん、肺がん、大腸がん、前立腺がん、乳がん、子宮頸がん、頭頸部がん、膠芽腫、悪性髄膜腫、中皮腫、黒色腫など）分析、売れ筋医薬品別（レブリミド、アバスチン、ハーセプチン、リツキサン、オプジーボ、グリベック、ベルケード、インブルビカ、イブランス、ジチガ、アリムタ、クタンディ、タルセバ、ペルジェタ、テモダールなど）分析、地域別分析、企業動向など含め、以下の構成でお届け致します。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・がん治療法の世界市場：用途別（血液がん、肺がん、大腸がん、前立腺がん、乳がん、子宮頸がん、頭頸部がん、膠芽腫、悪性髄膜腫、中皮腫、黒色腫など） ・がん治療法の世界市場：売れ筋医薬品別（レブリミド、アバスチン、ハーセプチン、リツキサン、オプジーボ、グリベック、ベルケード、インブルビカ、イブランス、ジチガ、アリムタ、クタンディ、タルセバ、ペルジェタ、テモダールなど） ・がん治療法の世界市場：地域別 ・企業動向 ... The use of targeted, biologic (immunotherapy) & other forms of therapies administered to treat cancer through oncology drugs is known as cancer therapeutics. The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Upsurge in collaboration between pharmaceutical companies, rise in cancer awareness & availability of oncology drugs, increase in cancer funding & research, and growth in geriatric population are the key factors that augment the growth of the cancer therapeutics market. Furthermore, rise in prevalence of...
  5. 血漿誘導体の世界市場：タイプ別（アルブミン、第VIII因子、第IX因子、免疫グロブリン、高力価免疫グロブリン、その他）、用途別（血友病、低ガンマグロブリン血症、免疫不全症、フォンヴィレブランド病（VWD）、その他）、エンドユーザー別（病院、診療所、その他）
    AMR805002 / Allied Market Research / 2018年4月20日 / 本資料は、血漿誘導体の世界市場について調べ、血漿誘導体の世界規模、市場動向、市場環境、タイプ別（アルブミン、第VIII因子、第IX因子、免疫グロブリン、高力価免疫グロブリン、その他）分析、用途別（血友病、低ガンマグロブリン血症、免疫不全症、フォンヴィレブランド病（VWD）、その他）分析、エンドユーザー別（病院、診療所、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・血漿誘導体の世界市場概要 ・血漿誘導体の世界市場環境 ・血漿誘導体の世界市場動向 ・血漿誘導体の世界市場規模 ・血漿誘導体の世界市場：タイプ別（アルブミン、第VIII因子、第IX因子、免疫グロブリン、高力価免疫グロブリン、その他） ・血漿誘導体の世界市場：用途別（血友病、低ガンマグロブリン血症、免疫不全症、フォンヴィレブランド病（VWD）、その他） ・血漿誘導体の世界市場：エンドユーザー別（病院、診療所、その他）...Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III. The global blood plasma derivatives market was valued at $23,613...
  6. 医療向け3Dイメージングサービスの世界市場：技術別（超音波、Ｘ線、MRI、その他）、用途別（腫瘍学、心臓病、整形外科、その他）、エンドユーザー別（診断センター、病院、研究センター）
    AMR805001 / Allied Market Research / 2018年4月20日 / 本資料は、医療向け3Dイメージングサービスの世界市場について調べ、医療向け3Dイメージングサービスの世界規模、市場動向、市場環境、技術別（超音波、Ｘ線、MRI、その他）分析、用途別（腫瘍学、心臓病、整形外科、その他）分析、エンドユーザー別（診断センター、病院、研究センター）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・医療向け3Dイメージングサービスの世界市場概要 ・医療向け3Dイメージングサービスの世界市場環境 ・医療向け3Dイメージングサービスの世界市場動向 ・医療向け3Dイメージングサービスの世界市場規模 ・医療向け3Dイメージングサービスの世界市場：技術別（超音波、Ｘ線、MRI、その他） ・医療向け3Dイメージングサービスの世界市場：用途別（腫瘍学、心臓病、整形外科、その他） ・医療向け3Dイメージングサービスの世界市場：エンドユーザー別（診断センター、病院、研究センター）...The global 3D medical imaging services market was valued at $149,492 million in 2016, and is expected to reach $236,809 million by 2023 at a CAGR of 6.7% during the forecast period. 3D imaging is a revolutionary optical imaging technology, which provides enhanced images on 2D platforms. These images are enhanced by the use of 3D image sensors and displays. The emergence of this imaging technique has allowed medical professionals to generate an in-depth image of suspect for better diagnosis. In addition, the technology is being applied in several noninvasive medical procedures such as ultrasound and tomography. Improved imaging and...
  7. 医療用ディスプレイの北米・ヨーロッパ市場：装置別、パネルサイズ別、解像度別、用途別
    AMR9NV131 / Allied Market Research / 2019年7月 / ...The North America and Europe medical display market was valued at $1,010.5 million in 2018 and is expected to reach $1,515.8 million by 2026 with a CAGR of 5.2% during the forecast period. Diagnosing patients accurately using Picture Archive Communication System (PACS) viewer that displays medical images on LCD monitors is important for detecting various diseases. Thus, medical display devices are significant tools for medical professionals to see images better than the physical films or CRT monitors. Streamlining the overall hospital operations and improving patient care in the healthcare system is important for proper diagnosis. Medical professionals such as surgeons,...
  8. シングルユースバイオプロセス材料の世界市場：製品別（プラスチック、シリコーン、その他）、エンドユーザー別（バイオ医薬品メーカー、ライフサイエンス研究開発・学術研究機関、CRO・メーカー）
    AMR8040040 / Allied Market Research / 2018年3月15日 / 本資料は、シングルユースバイオプロセス材料の世界市場について調べ、シングルユースバイオプロセス材料の世界規模、市場シェア、市場動向、市場環境、製品別（プラスチック、シリコーン、その他）分析、エンドユーザー別（バイオ医薬品メーカー、ライフサイエンス研究開発・学術研究機関、CRO・メーカー）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・シングルユースバイオプロセス材料の世界市場概要 ・シングルユースバイオプロセス材料の世界市場環境 ・シングルユースバイオプロセス材料の世界市場動向 ・シングルユースバイオプロセス材料の世界市場規模 ・シングルユースバイオプロセス材料の世界市場：市場シェア ・シングルユースバイオプロセス材料の世界市場：製品別（プラスチック、シリコーン、その他） ・シングルユースバイオプロセス材料の世界市場：エンドユーザー別（バイオ医薬品メーカー、ライフサイエンス研究開発・学術研究機関、CRO・メーカー）...Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent years. The key factors that drive the demand for single-use bioprocessing products include rise in adoption of single use technologies across pharmaceutical manufacturing facilities, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. This has further led to the development of single-use bioprocessing products using advanced materials as shelf-life of SUB products relies upon the stability of plastic ware and its sterility. The global single-use bioprocessing material market is segmented on...
  9. 不妊治療サービスの世界市場：手順別（ICSIを伴うIVF、IUI、ICSIを伴わないIVF、代理出産、その他）、サービス別（新鮮な非ドナー、冷凍の非ドナー、卵および胚銀行、新鮮なドナー、および冷凍のドナー）
    AMR9DC019 / Allied Market Research / 2019年10月 / 当調査レポートでは、不妊治療サービスの世界市場について調査・分析し、イントロダクション、エグゼクティブサマリ－、市場概要、手順別分析、サービス別分析、エンドユーザー別分析、地域別分析、企業概要などを含め以下の構成でお届けします。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・不妊治療サービスの世界市場：手順別（ICSIを伴うIVF、IUI、ICSIを伴わないIVF、代理出産、その他） ・不妊治療サービスの世界市場：サービス別（新鮮な非ドナー、冷凍の非ドナー、卵および胚銀行、新鮮なドナー、および冷凍のドナー） ・不妊治療サービスの世界市場：エンドユーザー別（不妊治療クリニック、病院、手術センター、臨床研究所） ・不妊治療サービスの世界市場：地域別 ・企業概要...The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026 Fertility services are services availed by people who are unable to conceive naturally. These services help infertile couples, single parents, and LGBT community to procreate and start a family. In vitro fertilization and other assisted reproductive technology (ART) procedures, surrogacy, and artificial insemination are some of the widely executed fertility services. The fertility service market is anticipated to grow considerably in the near future owing to different factors such as increase...
  10. デジタル病理学の世界市場：スキャナー、ソフトウェア、ストレージ＆通信システム
    AMR9NV034 / Allied Market Research / 2019年9月 / 当調査レポートでは、デジタル病理学の世界市場について調査・分析し、市場概要、製品別（スキャナー、ソフトウェア、ストレージ＆通信システム）分析、用途別（電話相談、疾病診断、創薬、トレーニング、教育）分析、エンドユーザー別（教育、臨床、製薬、バイオテクノロジー企業）分析、地域別分析、競争状況、企業動向など含め、以下の構成でお届け致します。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・デジタル病理学の世界市場：製品別（スキャナー、ソフトウェア、ストレージ＆通信システム） ・デジタル病理学の世界市場：用途別（電話相談、疾病診断、創薬、トレーニング、教育） ・デジタル病理学の世界市場：エンドユーザー別（教育、臨床、製薬、バイオテクノロジー企業） ・デジタル病理学の世界市場：地域別 ・競争状況 ・企業動向...The digital pathology market accounted for $512 million in 2018, and is expected to reach $1,390 million by 2026, registering a CAGR of 13.3% from 2019 to 2026. Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digital pathology solutions offer scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences. Efficient cost of digital pathology products, ease of virtual transportation of slides, and high efficiency of digital...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆